Literature DB >> 20396619

Molecular Imaging of Stem Cell Transplantation in Myocardial Disease.

Jaehoon Chung1, Phillip C Yang.   

Abstract

Stem cell therapy has been heralded as a novel therapeutic option for cardiovascular disease. In vivo molecular imaging has emerged as an indispensible tool in investigating stem cell biology post-transplantation into the myocardium and in evaluating the therapeutic efficacy. This review highlights the features of each molecular imaging modality and discusses how these modalities have been applied to evaluate stem cell therapy.

Entities:  

Year:  2010        PMID： 20396619      PMCID： PMC2853941          DOI： 10.1007/s12410-009-9001-4

Source DB:  PubMed          Journal:  Curr Cardiovasc Imaging Rep        ISSN： 1941-9074


  34 in total

Review 1.  The role of ultrasound in molecular imaging.

Authors:  H-D Liang; M J K Blomley
Journal:  Br J Radiol       Date:  2003       Impact factor: 3.039

2.  Feridex labeling of mesenchymal stem cells inhibits chondrogenesis but not adipogenesis or osteogenesis.

Authors:  Lisa Kostura; Dara L Kraitchman; Alastair M Mackay; Mark F Pittenger; Jeff W M Bulte
Journal:  NMR Biomed       Date:  2004-11       Impact factor: 4.044

3.  Monitoring of bone marrow cell homing into the infarcted human myocardium.

Authors:  Michael Hofmann; Kai C Wollert; Gerd P Meyer; Alix Menke; Lubomir Arseniev; Bernd Hertenstein; Arnold Ganser; Wolfram H Knapp; Helmut Drexler
Journal:  Circulation       Date:  2005-04-25       Impact factor: 29.690

4.  Manganese ion enhances T1-weighted MRI during brain activation: an approach to direct imaging of brain function.

Authors:  Y J Lin; A P Koretsky
Journal:  Magn Reson Med       Date:  1997-09       Impact factor: 4.668

5.  Multimodal evaluation of in vivo magnetic resonance imaging of myocardial restoration by mouse embryonic stem cells.

Authors:  Stephen L Hendry; Koen E A van der Bogt; Ahmad Y Sheikh; Takayasu Arai; Scott J Dylla; Micha Drukker; Michael V McConnell; Ingo Kutschka; Grant Hoyt; Feng Cao; Irving L Weissman; Andrew J Connolly; Marc P Pelletier; Joseph C Wu; Robert C Robbins; Phillip C Yang
Journal:  J Thorac Cardiovasc Surg       Date:  2008-06-06       Impact factor: 5.209

6.  Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts.

Authors:  Michael A Laflamme; Kent Y Chen; Anna V Naumova; Veronica Muskheli; James A Fugate; Sarah K Dupras; Hans Reinecke; Chunhui Xu; Mohammad Hassanipour; Shailaja Police; Chris O'Sullivan; Lila Collins; Yinhong Chen; Elina Minami; Edward A Gill; Shuichi Ueno; Chun Yuan; Joseph Gold; Charles E Murry
Journal:  Nat Biotechnol       Date:  2007-08-26       Impact factor: 54.908

7.  Assessment of the tissue distribution of transplanted human endothelial progenitor cells by radioactive labeling.

Authors:  Alexandra Aicher; Winfried Brenner; Maaz Zuhayra; Cornel Badorff; Schirin Massoudi; Birgit Assmus; Thomas Eckey; Eberhard Henze; Andreas M Zeiher; Stefanie Dimmeler
Journal:  Circulation       Date:  2003-04-14       Impact factor: 29.690

8.  Microbubbles targeted to intercellular adhesion molecule-1 bind to activated coronary artery endothelial cells.

Authors:  F S Villanueva; R J Jankowski; S Klibanov; M L Pina; S M Alber; S C Watkins; G H Brandenburger; W R Wagner
Journal:  Circulation       Date:  1998-07-07       Impact factor: 29.690

9.  Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts.

Authors:  Charles E Murry; Mark H Soonpaa; Hans Reinecke; Hidehiro Nakajima; Hisako O Nakajima; Michael Rubart; Kishore B S Pasumarthi; Jitka Ismail Virag; Stephen H Bartelmez; Veronica Poppa; Gillian Bradford; Joshua D Dowell; David A Williams; Loren J Field
Journal:  Nature       Date:  2004-03-21       Impact factor: 49.962

10.  Generic method for imaging transgene expression.

Authors:  Po-Wah So; Sarah Hotee; Amy H Herlihy; Jimmy D Bell
Journal:  Magn Reson Med       Date:  2005-07       Impact factor: 4.668
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.